A study of the probit model with latent variables in Phase I clinical trials

Publisher： Taylor & Francis Ltd

E-ISSN： 1563-5163|85|8|1621-1633

ISSN： 0094-9655

Source： Journal of Statistical Computation and Simulation, Vol.85, Iss.8, 2015-05, pp. : 1621-1633

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The adaptive accelerated biased coin design for phase I clinical trials

By Jia Nan   Braun Thomas M.  

Journal of Applied Statistics, Vol. 38, Iss. 12, 2011-12 ,pp. : 2911-2924

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical Properties of a Modified Accelerated Design for Phase I Cancer Clinical Trials

By Liu Jun  

Communications in Statistics: Theory and Methods, Vol. 36, Iss. 15, 2007-01 ,pp. : 2741-2759

Taylor & Francis Ltd

Access to resources Recommend Favorite

A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches

By Su Zheng  

Journal of Applied Statistics, Vol. 38, Iss. 7, 2011-07 ,pp. : 1493-1498

Taylor & Francis Ltd

Access to resources Recommend Favorite

Using Data Augmentation to Facilitate Conduct of Phase I–II Clinical Trials With Delayed Outcomes

By Jin Ick Hoon   Liu Suyu   Thall Peter F.   Yuan Ying  

Journal of the American Statistical Association, Vol. 109, Iss. 506, 2014-04 ,pp. : 525-536

Taylor & Francis Ltd

Access to resources Recommend Favorite

Composite Likelihood Estimation for Multivariate Probit Latent Traits Models

By Feddag M.-L.  

Communications in Statistics: Theory and Methods, Vol. 42, Iss. 14, 2013-07 ,pp. : 2551-2566

Taylor & Francis Ltd

Access to resources Recommend Favorite